Revenue from Contracts with Customers

6 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2020 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (“OEM”). Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and six-month periods ended June 30, 2021 and 2020 (in thousands):

	Three Months Ended						Three Months Ended
	June 30, 2021						June 30, 2020
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	63,235	$	42,365	$	105,600	$	42,614	$	30,021	$	72,635
Cardiac Intervention		33,217		52,436		85,653		22,698		43,307		66,005
Custom Procedural Solutions		27,392		21,244		48,636		23,383		21,936		45,319
OEM		27,420		4,983		32,403		23,607		4,611		28,218
Total		151,264		121,028		272,292		112,302		99,875		212,177
Endoscopy
Endoscopy devices		7,507		526		8,033		5,838		356		6,194
Total	$	158,771	$	121,554	$	280,325	$	118,140	$	100,231	$	218,371

	Six Months Ended						Six Months Ended
	June 30, 2021						June 30, 2020
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	120,101	$	78,413	$	198,514	$	98,416	$	61,294	$	159,710
Cardiac Intervention		62,468		97,922		160,390		51,293		87,303		138,596
Custom Procedural Solutions		52,284		41,773		94,057		48,797		44,143		92,940
OEM		50,310		10,027		60,337		47,274		9,201		56,475
Total		285,163		228,135		513,298		245,780		201,941		447,721
Endoscopy
Endoscopy devices		14,980		960		15,940		13,416		759		14,175
Total	$	300,143	$	229,095	$	529,238	$	259,196	$	202,700	$	461,896